ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2025
Dietary Fenbendazole Treatment Does Not Impair Skilled Forelimb Motor Function in C57BL/6J Mice.
Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fenbendazole (FBZ) treatment for pinworm infections is generally safe and effective but not without concern for potential research complications in its application to laboratory animal colonies. Previously, dietary FBZ was found to impair motor performance in C57BL/6N mice, an effect that endured at least 2 wk posttreatment. These findings raised the possibility that FBZ treatment would complicate our own research on poststroke motor function in C57BL/6J mice. Here we present the results of a study that tested this possibility in the context of facility-wide FBZ treatment based on repeated measures in a skilled reaching task that is extremely sensitive to forelimb motor impairments. Mice of both sexes that were proficient in the reaching task were measured in their performance of the task in each of the 4 wk preceding, 7 wk during, and 2 wk after dietary FBZ treatment that alternated weekly between therapeutic and subtherapeutic doses. There was no indication of a notable decrement or other change in reaching performance during or after FBZ treatment (mean ± SE percent success before, during, and after treatment = 57 ± 2, 53 ± 2, and 60 ± 2; n = 20). Performance stability in FBZ-treated mice was similar to that of untreated mice. These results are significant for revealing a lack of noticeable influence of FBZ on a commonly used measure of motor function in a widely used mouse strain. The difference in FBZ effects relative to the prior study could reflect substrain-dependency (6N compared with 6J) and/or differences in motor behavioral measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.